BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11280729)

  • 1. Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicase.
    Lebel M; Cardiff RD; Leder P
    Cancer Res; 2001 Mar; 61(5):1816-9. PubMed ID: 11280729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.
    Hakem R; de la Pompa JL; Elia A; Potter J; Mak TW
    Nat Genet; 1997 Jul; 16(3):298-302. PubMed ID: 9207798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Werner and Bloom helicases are involved in DNA repair in a complementary fashion.
    Imamura O; Fujita K; Itoh C; Takeda S; Furuichi Y; Matsumoto T
    Oncogene; 2002 Jan; 21(6):954-63. PubMed ID: 11840341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.
    Philipp-Staheli J; Kim KH; Liggitt D; Gurley KE; Longton G; Kemp CJ
    Oncogene; 2004 Jan; 23(4):905-13. PubMed ID: 14647411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
    Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
    Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice.
    Martín-Caballero J; Flores JM; García-Palencia P; Serrano M
    Cancer Res; 2001 Aug; 61(16):6234-8. PubMed ID: 11507077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and functional interaction between p53 and the Werner's syndrome protein.
    Blander G; Kipnis J; Leal JF; Yu CE; Schellenberg GD; Oren M
    J Biol Chem; 1999 Oct; 274(41):29463-9. PubMed ID: 10506209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
    Damo LA; Snyder PW; Franklin DS
    Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1).
    Op De Beeck A; Sobczak-Thepot J; Sirma H; Bourgain F; Brechot C; Caillet-Fauquet P
    J Virol; 2001 Nov; 75(22):11071-8. PubMed ID: 11602746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional analysis of yeast homologue gene associated with human DNA helicase causative syndromes].
    Miyajima A
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2002; (120):53-74. PubMed ID: 12638184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases.
    Siitonen HA; Kopra O; Kääriäinen H; Haravuori H; Winter RM; Säämänen AM; Peltonen L; Kestilä M
    Hum Mol Genet; 2003 Nov; 12(21):2837-44. PubMed ID: 12952869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p21 promoted tumorigenesis in the background of telomere dysfunctions induced by TRF2 and Wrn deficiency.
    Si X; Shao C; Li J; Jia S; Tang W; Zhang J; Yang J; Wu X; Luo Y
    Int J Biol Sci; 2018; 14(2):165-177. PubMed ID: 29483835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.
    Modestou M; Puig-Antich V; Korgaonkar C; Eapen A; Quelle DE
    Cancer Res; 2001 Apr; 61(7):3145-50. PubMed ID: 11306500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic cooperation between the Werner syndrome protein and poly(ADP-ribose) polymerase-1 in preventing chromatid breaks, complex chromosomal rearrangements, and cancer in mice.
    Lebel M; Lavoie J; Gaudreault I; Bronsard M; Drouin R
    Am J Pathol; 2003 May; 162(5):1559-69. PubMed ID: 12707040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer.
    Wirtenberger M; Frank B; Hemminki K; Klaes R; Schmutzler RK; Wappenschmidt B; Meindl A; Kiechle M; Arnold N; Weber BH; Niederacher D; Bartram CR; Burwinkel B
    Carcinogenesis; 2006 Aug; 27(8):1655-60. PubMed ID: 16501249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Modulates the exonuclease activity of Werner syndrome protein.
    Brosh RM; Karmakar P; Sommers JA; Yang Q; Wang XW; Spillare EA; Harris CC; Bohr VA
    J Biol Chem; 2001 Sep; 276(37):35093-102. PubMed ID: 11427532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camptothecin sensitivity in Werner syndrome fibroblasts as assessed by the COMET technique.
    Lowe J; Sheerin A; Jennert-Burston K; Burton D; Ostler EL; Bird J; Green MH; Faragher RG
    Ann N Y Acad Sci; 2004 Jun; 1019():256-9. PubMed ID: 15247024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic dissection of the role of p21Cip1/Waf1 in p53-mediated tumour suppression.
    Efeyan A; Collado M; Velasco-Miguel S; Serrano M
    Oncogene; 2007 Mar; 26(11):1645-9. PubMed ID: 16964282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.